The Legislature’s medical-marijuana subcommittee voted 6-4 Wednesday to overturn a key part of Initiated Measure 26 and make home-cultivated cannabis illegal in South Dakota. But the panel fell... South Dakota lawmakers’ panel wants home-cultivated medical cannabis to be illegal, contrary to IM 26

The Legislature’s medical-marijuana subcommittee voted 6-4 Wednesday to overturn a key part of Initiated Measure 26 and make home-cultivated cannabis illegal in South Dakota.

But the panel fell one aye short of recommending the repeal of part of another state law that affects medical practitioners.

Physicians currently are required to say that their patients are likely to receive a therapeutic or palliative benefit when a patient applies for a medical card from the state Department of Health.

The South Dakota Association of Healthcare Organizations however wants it removed. The subcommittee’s vote was 5-4. That meant it failed because a majority of six was needed from its 11 members.

The recommendations go next in the coming weeks to the Legislature’s full marijuana-study committee for a second vote on whether they should advance to the 2022 legislative session.

Representative Fred Deutsch said he wasn’t comfortable with the change for physicians.

“We have a diagnosis-based medical system,” Deutsch, a retired chiropractor, said. Removing the requirement would make physicians “just a front” and would do “a great disservice to our public.” He added, “Let’s not turn our medical into a recreational program.” [Read more at Keloland]

MJ Shareholders avatar

MJ Shareholders

MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers

No comments so far.

Be first to leave comment below.

( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )